Large Zealand shareholder considers investing in Orphazyme

Dutch family foundation Van Herk, which owns a fifth of shares in Zealand Pharma, is considering buying shares in another Danish biotech company: Orphazyme.

Orphazyme's research director Thomas Kirkegaard Jensen. Photo: Anne Bæk / Ritzau Scanpix

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles